TrialTrials2016

A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers.

Francis H Y Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.